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Abstract: The synthesis, characterization and X-ray crystal structure of 2-(4-chloro-
phenyl)-7-methylpyrrolo[1,2-b]pyridazine are reported. The compound crystallizes in the 
space group P21/c (No.14) with a =3.8568(1), b = 11.0690(3), c = 26.4243(7) Å, β = 
92.777(1)° and Z = 4. Accurate molecular parameters for the novel heterocyclic system 
were obtained from intensity data collected at 113K. The molecule assumes a planar 
conformation in the crystal and the packing is based on π-π stacking with interplanar 
spacing 3.400 Å, typical of aromatic molecules with potential for displaying useful 
optical properties. 
 





The fused heterocyclic rings resulting from the condensation of pyridazine with a pyrrole [1,2] or 
oxazole [3] ring have interesting optical properties, offering new strategies and feasible ways to obtain 
stable light-emitting organic compounds. These condensed heterocycles are highly fluorescent in the 
solid state and in solution. Pyrrolo[1,2-b]pyridazine derivatives have also attracted attention in recent 
years due to their biological activity [4-10]. To our knowledge, only one X-ray structure of a 
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substituted pyrrolo[1,2-b]pyridazine has been reported to date, namely that of compound 1 [2], shown 
in Scheme 1. 
 


























As suggested [2], the expansion of the π-electron system could have strong influences on the 
fluorescent properties of the compounds under discussion and represents the key step in the design of 
novel optically active materials. It is also known that π-π stacking interactions in the solid state are 
needed in order to have an extended π system, thus enabling electron mobility in the material. Such 
interactions are present in conjugated planar structures and to verify this hypothesis, the X-ray 
structure of 4 was determined.  
 
Results and Discussion 
 
2-(4-Chlorophenyl)-7-methylpyrrolo[1,2-b]pyridazine (4) was prepared from the ester 2 [11], 
under basic conditions, followed by thermal decarboxylation of the corresponding acid 3. 
 
















1. HO- / H2O
2. H+ - CO2
 
                                   2                                 3                               4 
  
The structure of the pyrrolo[1,2-b]pyridazine 4 was confirmed by elemental analysis and NMR 
spectroscopy.  In its 1H-NMR the methyl group (δ = 2.62 ppm) appeared as a doublet (J = 0.7 Hz) due 
to the coupling with H-6. The H-5 proton (δ = 6.67 ppm) appeared as a doublet with coupling constant 
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J = 4.3 Hz, whereas H-6 (δ = 6.47 ppm) gave a double quartet with coupling constants of 4.3 and 0.7 
Hz corresponding to the coupling with H-5 and methyl protons. The H-3 and H-4 protons from the 
pyridazine moiety gave two doublets at 6.82 and 7.72 ppm (J = 9.3 Hz). Also, the protons from the 
benzene ring appeared as two doublets with J = 8.6 Hz. 
The 13C-NMR data for compound 4 were in agreement with the structure assignment. The 
chemical shifts of tertiary carbon atoms were established by the HETCOR experiment. In turn, the 
chemical shift from 148.2 ppm was attributed to the C-2 atom due to its vicinity with the N-2 atom.   
Figure 1 shows the molecular structure of 4 in the crystal. The maximum deviation of any atom 
from the least-squares (LS) plane including the nine non-H atoms of the pyrrolopyridazine moiety is 
0.016(3) Å (for atom C16). This system is practically coplanar with the chlorophenyl residue (dihedral 
angle between LS planes 2.4(1)º).   
 
Figure 1.  Molecular structure of 4 showing (left) atomic numbering and thermal 
ellipsoids drawn at the 50% probability level [12] and (right) π-π stacking in 













Salient geometrical parameters for the heterocyclic system were compared with those in 1 [2]. 
While both crystal structures were determined from low temperature intensity data (113 K for 4, 100 K 
for 1), it is noteworthy that the standard deviations in bond lengths for 4 (0.003-0.004 Å) are an order 
of magnitude smaller than those reported for 1 (0.037 Å [2]), justifying our reported analysis and 
allowing a more precise description of this heterocyclic system. The N-N bond length in 4 is 1.359(3) 
Å and the length C8-N9 is 1.314(3) Å. Given the relative standard deviations, these values overlap 
those quoted for 1 [2].  The carbon-carbon bonds in the 5-membered ring of 4 nominally span a 
narrower range (1.378(4)-1.396(5) Å) than that observed in 1 (1.383-1.426 Å). This is attributed to 
very significant electronic effects operating in 1 owing to the presence of two methyl ester substituents 
(Scheme 1).   The asymmetry of the pyridazine ring of 4 is evident in Figure 1. In particular, the 
endocyclic angles subtended at N9 and C11 are equal (115.8(2), 115.7(3)º respectively) and 
significantly smaller than that subtended at N10 (126.1(2)º). Ring conjugation is reflected in the C5-C8 
length of 1.490(4) Å, typical of e.g. biphenyls.  
The likelihood of graphitic-type π-π stacking of these aromatic molecules in the crystal (Figure 1, 
right) was originally inferred from observation of the very short unit cell a-axis of 3.8568(1) Å.  
Molecules of 4 stack by translation along the x-direction forming columns. Crystal packing viewed 
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parallel to the stacking direction is shown in Figure 2. Because of their steep inclinations to the bc-face 
of the unit cell, molecules of 4 stack in an offset face-to-face mode (Figure 2, right) with an interplanar 
separation of 3.400 Å (i.e. significantly < a). This distance matches those reported in crystals of 1 and 
related heterocyclic aromatic systems (range 3.31-3.39 Å), for which it has been suggested that the 
strength of π stacking is sufficient for applications requiring high electron mobility [2]. The stacking 
offset in 4 results in the shortest centroid⋅⋅⋅centroid distance (3.635 Å) being that between the 
pyridazine ring of a molecule at x, y, z and the pyrrole ring of the translated molecule at 1+x, y, z. The 
presence of only weak π-π stacking interactions in crystals of 4 is consistent with its low melting point 
of 54-55ºC. The X-ray analysis thus shows conclusively that the preparation and crystallization of 4 
have achieved the desired goal in the solid state, namely extension of the π-electron system of the 
pyrrolo[1,2-b]pyridazine. 
 


















Melting points were determined on a Boëtius hot plate and are uncorrected. The NMR spectra were 
recorded on a Varian Gemini 300 BB instrument, operating at 300 MHz for 1H and 75 MHz for 13C. IR 






Ethyl 2-(4-chlorophenyl)-7-methylpyrrolo[1,2-b]pyridazine-5-carboxylate (2, 1 g, 3.2 mmoles) [11] 
was heated under reflux, under continuous stirring, for 4 hours, with 10 % NaOH (20 mL). After 
acidification with concentrated HCl, the precipitate was collected by filtration, washed with water and 
air dried. Recrystallization from DMF afforded white crystals with m.p. 279-281 0C. Yield 97 %. Anal. 
Calcd. for C15H11ClN2O2: C 62.84, H 3.87, Cl 12.37, N 9.77. Found C 63.22, H 4.15, Cl 12.73, N 
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10.07; 1H-NMR (CDCl3 + TFA; δ, ppm; J, Hz): 2.63 (d, 3H, 0.8; 7-Me); 7.20 (q, 1H, 0.8; H-6); 7.42 
(d, 1H, 9.4; H-3); 7.50 (d, 2H, 8.6, H-3', H-5'); 7.95 (d, 2H, 8.6, H-2', H-6'); 8.48 (d, 1H, 9.4; H-4); 
13C-NMR (CDCl3 + TFA; δ, ppm): 11.0 (7-Me); 100.2 (C-5); 113.7, 115.1,127.8 (C-3, C-4, C-6); 





Carboxylic acid 3 (0.5 g, 1.7 mmoles) was heated above its melting point (bath temperature 290-5 
ºC) until evolution of CO2 ceased (ca. 5 min.). After cooling, the crude product was dissolved in a 
minimum amount of dichloromethane and purified by column chromatography on neutral Al2O3 using 
CH2Cl2 as eluent. The solvent was evaporated, the residue crystallized from isopropanol affording 
yellow crystals of 4, m.p. 54-5 0C. Yield 62 %. Anal. Calcd. for C14H11ClN2: C 69.28, H 4.57, Cl 
14.61, N 11.54. Found C 69.67, H 4.88, Cl 14.97 N 11.88. IR (CH2Cl2; cm-1): 1100, 1490, 1520, 1590, 
1615, 2905; 1H-NMR (CDCl3; δ, ppm; J, Hz): 2.62 (s, 3H, 0.7; 7-Me); 6.47 (d, 1H, 4.3; H-5); 6.67 (dq, 
1H, 4.3, 0.7, H-6); 6,82 (d, 1H, 9.3, H-3); 7.42 (d, 2H, 8.6, H-3', H-5'); 7.72 (d,1H, 9.3; H-4); 7.90 (d, 
2H, 8.6, H-2', H-6'); 13C-NMR (CDCl3; δ, ppm): 11.2 (7-Me); 98.7 (C-5); 106.1 (C-3); 112.6 (C-6); 
124.9, 125.9 (C-4a, C-7); 127.1 (C-4); 127.9, 128,8 (C-2', C-3', C-5', C-6'); 135.1, 135.6 (C-1', C-4'); 
148,2 (C-2). 
 
X-ray analysis of 4 
  
A small fragment was cut from a needle of 4 and mounted on a Nonius Kappa CCD four-circle 
diffractometer. Intensity data were collected using Mo-Kα radiation (λ = 0.71069 Å) with the crystal 
cooled in a stream of N2 from a Cryostream cooler (Oxford Cryosystems, UK). The data-collection 
strategy (program COLLECT [13]) involved suitable combinations of 1.0° ϕ- and 0.60º ω-scans. 
Program DENZO-SMN [14] was used for cell refinement (15365 reflections in the θ-range 0.21-
27.48°) and data reduction. The SADABS program [15] was used to apply absorption corrections. The 
structure was solved with the SHELXS86 program [16] and refined on F2 with SHELXL97 [17], all 
non-hydrogen atoms being modelled anisotropically.  All H atoms were located in difference electron-
density maps and were included in idealized positions in a riding model with isotropic thermal 
parameters equal to 1.2 times those of their parent atoms.  In the final cycles of refinement, least-
squares weights of the form w = 1/[σ2(Fo)2 + (aP)2 +bP], P = [max(Fo2, 0) + 2Fc2]/3 were employed. 
Molecular parameters were calculated with PLATON [18] and programs ORTEP-3 [12] and WebLab 
Viewer Pro3.7 [19] were used for illustrations. Crystallographic data for 4 are listed in Table 1.  
CCDC-254383 contains the supplementary crystallographic data for this paper.  These data can be 
obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge 
Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK: fax: (internat.) +44-
1223/336-033; Email: deposit@ccdc.cam.ac.uk]. 
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Table 1. Crystallographic parameters for 4 
Chemical formula 
Formula weight 















Residuals: R1, wR2 [I > 2σ(I)] 
Goodness of Fit, S 
Max. shift/error 
Max. peak in final ∆ρ synthesis 








a = 3.8568(1) Å    
b = 11.0690(3)  Å    
c = 26.4243(7) Å  
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